Latest Health & pharmaceuticals news
Company sells some rights to respiratory treatments to Covis Pharma
Analysts nevertheless argue improved earnings growth already priced in
Company sees good performance in US and Emerging markets
Takeda’s acquisition of group on track to close in first half of 2019
Blue-chip drugmaker benefits from demand for new shingles vaccine
Sanofi shares are higher Wednesday, after the French pharma firm reported better-than-expected third quarter earnings and raised its full-year outlook.
Anglo-Swedish group could land nearly $1bn from deal
Novartis shares are higher as the Swiss pharma group enters an agreement with Pfizer to collaborate on the development of a drug to treat NASH liver disease.
Move comes as companies look to gain EU approval for merger
BMO Capital Markets trims earnings forecasts
Anglo-Swedish pharmco snaps up 9.8% equity stake in French biotech company
Bayer shares are lower Tuesday, following news a US judge has upheld the verdict that it's weed killer products, RoundUp and Ranger Pro, contain carcinogenic properties.
Deutsche Bank weighs in on trial results
EMA’s CHMP issues positive opinion for pharmco’s Bevespi Aerosphere
Novartis shares are higher Thursday, as the Swiss drugs maker announced the purchase of US cancer drug specialist, Endocyte and also raised its 2018 earnings guidance.
Japanese firm moves closer to completing deal with London-listed group
Pharmco could maintain decision not to invest
Bayer shares are lower Friday, reversing earlier gains, as the US judge at the initial hearing of Bayer's retrial request in the RoundUp cancer case, suggested she could order a retrial or reduce the damages awarded in August.
Move follows group’s no-payment pledge in 2013
Pharmco receives $200m payment for Atacand
Novartis shares are higher Tuesday, after the Swiss drugs maker announced it was cutting 2,550 jobs across its Swiss and UK sites.
Shareholder claims combined value of groups less than each on its own
Company offloads water bottling business
Bayer shares are higher Wednesday, as its Monsanto unit has filed papers with a California court requesting it overturn the Roundup case verdict.